secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2022-11-28T23:59:59+00:00
Accession:  0001193125-22-293409
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics receives Nasdaq extension to May 22, 2023 to regain minimum bid price compliance
--------------------------------------------------------------------------------

- Received second letter from Nasdaq granting 180-day extension to May 22, 2023 to regain minimum bid price compliance.
- Previously notified on May 24, 2022 of bid price below $1.00; original compliance period ended Nov 21, 2022.
- Company will evaluate options including a reverse stock split, if approved by stockholders.
- Failure to regain compliance by May 22, 2023 may result in delisting; rights to appeal exist.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312522293409/0001193125-22-293409-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312522293409/d404851d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-293409

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer